{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:39:53Z","timestamp":1792517993717,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009381","name":"International Medical University","doi-asserted-by":"publisher","award":["IMU 398\/2023"],"award-info":[{"award-number":["IMU 398\/2023"]}],"id":[{"id":"10.13039\/501100009381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128554","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:21:04Z","timestamp":1775683264000},"page":"128554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Heterologous DNA prime\u2013crude tachyzoite lysate antigen boost targeting MIC8 confers protection against acute and chronic Toxoplasma gondii infection in mice"],"prefix":"10.1016","volume":"80","author":[{"given":"Asaga Mac","family":"Peter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Ambu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian D.","family":"Amalraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushela D.","family":"Somanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikumar","family":"Chakravarthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128554_bb0005","series-title":"Toxoplasmosis of animals and humans","author":"Dubey","year":"2010"},{"issue":"9425","key":"10.1016\/j.vaccine.2026.128554_bb0010","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"12\u221213","key":"10.1016\/j.vaccine.2026.128554_bb0170","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2026.128554_bb0015","series-title":"Infectious diseases of the fetus and newborn infant","first-page":"918","article-title":"Toxoplasmosis","author":"Remington","year":"2011"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128554_bb0020","article-title":"Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis","volume":"33","author":"Elsheikha","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128554_bb0025","series-title":"Toxoplasma gondii: The model apicomplexan","author":"Weiss","year":"2014"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128554_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/359082a0","article-title":"Virulent strains of toxoplasma gondii comprise a single clonal lineage","volume":"359","author":"Sibley","year":"1992","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128554_bb0040","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrmicro2858","article-title":"Modulation of innate immunity by toxoplasma gondii virulence effectors","volume":"10","author":"Hunter","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128554_bb0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.pt.2005.08.001","article-title":"Differences among the three major strains of toxoplasma gondii and their specific interactions with the infected host","volume":"21","author":"Saeij","year":"2005","journal-title":"Trends Parasitol"},{"issue":"4851","key":"10.1016\/j.vaccine.2026.128554_bb0050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-\u03b3: the major mediator of resistance against toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128554_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","article-title":"Simultaneous depletion of CD4+ and CD8+ t lymphocytes is required to reactivate chronic infection with toxoplasma gondii","volume":"149","author":"Gazzinelli","year":"1992","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128554_bb0060","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","article-title":"B cells are essential for vaccination-induced resistance to virulent toxoplasma gondii","volume":"68","author":"Sayles","year":"2000","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128554_bb0065","first-page":"114","article-title":"Sequential protein secretion from three distinct organelles of toxoplasma gondii accompanies invasion of human fibroblasts","volume":"73","author":"Carruthers","year":"1997","journal-title":"Eur J Cell Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128554_bb0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1242\/jcs.022350","article-title":"Microneme protein 8 is a new essential invasion factor in Toxoplasma gondii","volume":"121","author":"Kessler","year":"2008","journal-title":"J Cell Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128554_bb0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmeth1134","article-title":"Rapid control of protein level in the apicomplexan toxoplasma gondii","volume":"4","author":"Herm-G\u00f6tz","year":"2007","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0080","first-page":"1495","article-title":"Protective immunity induced by a DNA vaccine encoding Toxoplasma gondii microneme protein 8 against acute infection in mice","volume":"111","author":"Liu","year":"2012","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2026.128554_bb0085","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128554_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"issue":"37","key":"10.1016\/j.vaccine.2026.128554_bb0100","first-page":"5537","article-title":"Vaccination with Toxoplasma gondii GRA14 elicits immunoprotection against acute and chronic toxoplasmosis in mice","volume":"37","author":"Pagheh","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128554_bb0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-toxoplasma gondii vaccines: challenges, opportunities, and perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128554_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.vaccine.2026.128554_bb0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0195","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/159.4.736","article-title":"Recent primary toxoplasma infection indicated by a low avidity of specific IgG","volume":"159","author":"Hedman","year":"1989","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128554_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128554_bb0220","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","article-title":"Intracellular cytokine optimization and standard operating procedure","volume":"1","author":"Lamoreaux","year":"2006","journal-title":"Nat Protoc"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128554_bb0225","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63","author":"Leng","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128554_bb0160","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1550-7408.1997.tb05965.x","article-title":"Bradyzoite-induced murine toxoplasmosis: stage conversion, pathogenesis, and tissue cyst formation in mice fed bradyzoites of different strains of toxoplasma gondii","volume":"44","author":"Dubey","year":"1997","journal-title":"J Eukaryot Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128554_bb0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0169-4758(96)80642-9","article-title":"Developmental differentiation between tachyzoites and bradyzoites of toxoplasma gondii","volume":"12","author":"Gross","year":"1996","journal-title":"Parasitol Today"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128554_bb0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128554_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0020-7519(99)00170-8","article-title":"Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in toxoplasma gondii, and its use for diagnostic and quantitative PCR","volume":"30","author":"Homan","year":"2000","journal-title":"Int J Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128554_bb0125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/IAI.70.2.434-443.2002","article-title":"CD8+-T-cell immunity against toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4+ t cells","volume":"70","author":"Casciotti","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of t-cell-mediated immunity during toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0185","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2353\/ajpath.2010.090825","article-title":"Removal of toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ t cells","volume":"176","author":"Suzuki","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2026.128554_bb0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128554_bb0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"issue":"38","key":"10.1016\/j.vaccine.2026.128554_bb0205","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1016\/j.vaccine.2012.06.081","article-title":"Enhancement of protective immune responses induced by toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy","volume":"30","author":"Min","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128554_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijfoodmicro.2010.02.027","article-title":"Direct detection and genotyping of toxoplasma gondii in meat samples using magnetic capture and PCR","volume":"139","author":"Opsteegh","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.vaccine.2026.128554_bb0210","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13071-015-0902-6","article-title":"Diagnosis of toxoplasmosis and typing of toxoplasma gondii","volume":"8","author":"Liu","year":"2015","journal-title":"Parasit Vectors"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128554_bb0135","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.145.10.3438","article-title":"Class i MHC genes and CD8+ t cells determine cyst number in toxoplasma gondii infection","volume":"145","author":"Brown","year":"1990","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128554_bb0215","first-page":"732","article-title":"A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice","volume":"74","author":"Suzuki","year":"1991","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128554_bb0140","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2026.128637","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:01:33Z","timestamp":1792515693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S0264410X26003622"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128554","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous DNA prime\u2013crude tachyzoite lysate antigen boost targeting MIC8 confers protection against acute and chronic Toxoplasma gondii infection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128554"}}